BTM-1086

• Description :

  BTM-1086 is a potent anti-ulcer and gastric secretory inhibiting agent.

• UNSPSC :

  12352005

• Target :

  MAChR

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/1,5-Benzothiazepin-4_5H_-one,_2,3-dihydro-3-[_4-methyl-1-piperazinyl_methyl]-2-phenyl-,__2R,3S_-rel-.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C1[C@H](CN2CCN(C)CC2)[C@H](C3=CC=CC=C3)SC4=CC=CC=C4N1

• Molecular Formula :

  C21H25N3OS

• Molecular Weight :

  367.51

• References & Citations :

  [1]Eltze M, et al. Affinity profiles of BTM-1086 and BTM-1041 at muscarinic receptor subtypes and at H1- and alpha 1-receptors. Eur J Pharmacol. 1989 Nov 7;170 (3) :225-34.|[2]Hajimu Y, et al. Antiulcer Effect of (-) -cis-2, 3-Dihydro-3- (4-Methylpiperazinylmethyl) -2-Phenyl-1, 5-Benzothiazepin-4- (5H) -One Hydrochloride (BTM-1086) in Experimental Animals. Japan J Pharmacol. 41, 283-292 (1986) .

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [72293-17-5]